Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Hepatitis C virus | Hepatitis C virus NS5B RNA-dependent RNA polymerase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | D-amino acid dehydrogenase | 0.003 | 0.0621 | 0.5 |
Schistosoma mansoni | glycerol-3-phosphate dehydrogenase | 0.003 | 0.0621 | 0.0621 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0012 | 0.0107 | 0.0107 |
Echinococcus granulosus | ATP dependent DNA helicase PIF1 | 0.0034 | 0.0737 | 0.7849 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0034 | 0.0737 | 1 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF6, putative | 0.0034 | 0.0737 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0784 | 0.0784 |
Schistosoma mansoni | NAD dehydrogenase | 0.003 | 0.0621 | 0.0621 |
Brugia malayi | cDNA sequence BC016226 | 0.003 | 0.0621 | 0.6623 |
Onchocerca volvulus | Dimethylglycine dehydrogenase, mitochondrial homolog | 0.003 | 0.0621 | 0.5 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0041 | 0.0938 | 1 |
Mycobacterium leprae | PROBABLE D-AMINO ACID OXIDASE AAO | 0.0355 | 1 | 1 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0034 | 0.0737 | 1 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0034 | 0.0737 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0621 | 0.0621 |
Echinococcus multilocularis | glycerol 3 phosphate dehydrogenase | 0.003 | 0.0621 | 0.6623 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0012 | 0.0107 | 0.0107 |
Giardia lamblia | Rrm3p helicase | 0.0034 | 0.0737 | 1 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF7 | 0.0034 | 0.0737 | 1 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0012 | 0.0107 | 0.1145 |
Echinococcus multilocularis | voltage gated potassium channel | 0.0012 | 0.0107 | 0.1145 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0034 | 0.0737 | 1 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0041 | 0.0938 | 0.0938 |
Plasmodium falciparum | FAD-dependent glycerol-3-phosphate dehydrogenase, putative | 0.003 | 0.0621 | 0.5 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF6 | 0.0034 | 0.0737 | 1 |
Toxoplasma gondii | FAD-dependent glycerol-3-phosphate dehydrogenase | 0.003 | 0.0621 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0034 | 0.0737 | 0.8551 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0012 | 0.0107 | 0.1145 |
Echinococcus multilocularis | ATP dependent DNA helicase PIF1 | 0.0034 | 0.0737 | 0.7849 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0041 | 0.0938 | 1 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0038 | 0.0861 | 1 |
Brugia malayi | RE18450p | 0.003 | 0.0621 | 0.6623 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0107 | 0.0107 |
Schistosoma mansoni | fad oxidoreductase | 0.003 | 0.0621 | 0.0621 |
Echinococcus granulosus | voltage gated potassium channel | 0.0012 | 0.0107 | 0.1145 |
Onchocerca volvulus | Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial homolog | 0.003 | 0.0621 | 0.5 |
Brugia malayi | dimethylglycine dehydrogenase, mitochondrial precursor, putative | 0.003 | 0.0621 | 0.6623 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0044 | 0.1046 | 0.1046 |
Schistosoma mansoni | ATP:guanidino kinase (Smc74) | 0.003 | 0.0621 | 0.0621 |
Toxoplasma gondii | hypothetical protein | 0.003 | 0.0621 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0737 | 0.0737 |
Echinococcus granulosus | FAD dependent oxidoreductase domain containing protein | 0.003 | 0.0621 | 0.6623 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0044 | 0.1046 | 0.1046 |
Echinococcus granulosus | glycerol 3 phosphate dehydrogenase | 0.003 | 0.0621 | 0.6623 |
Onchocerca volvulus | Putative fad oxidoreductase | 0.003 | 0.0621 | 0.5 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0038 | 0.0861 | 1 |
Mycobacterium ulcerans | D-amino acid oxidase Aao | 0.0355 | 1 | 1 |
Entamoeba histolytica | DNA repair and recombination protein, putative | 0.0034 | 0.0737 | 1 |
Mycobacterium tuberculosis | Probable D-amino acid oxidase Aao | 0.0325 | 0.9147 | 1 |
Schistosoma mansoni | fad oxidoreductase | 0.003 | 0.0621 | 0.0621 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0034 | 0.0737 | 1 |
Echinococcus multilocularis | FAD dependent oxidoreductase domain containing protein | 0.003 | 0.0621 | 0.6623 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0621 | 0.0621 |
Brugia malayi | Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog | 0.0012 | 0.0107 | 0.1145 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0621 | 0.0621 |
Brugia malayi | pyruvate dehydrogenase phosphatase regulatory subunit precursor | 0.003 | 0.0621 | 0.6623 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0041 | 0.0938 | 1 |
Loa Loa (eye worm) | glycerol-3-phosphate dehydrogenase | 0.003 | 0.0621 | 0.0621 |
Plasmodium vivax | FAD-dependent glycerol-3-phosphate dehydrogenase, putative | 0.003 | 0.0621 | 0.5 |
Schistosoma mansoni | d-amino acid oxidase | 0.0355 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 15 uM | Inhibitory concentration for NS5B RNA-dependent RNA polymerase of Hepatitis C virus | ChEMBL. | 15454222 |
IC50 (binding) | = 15 uM | Inhibitory concentration for NS5B RNA-dependent RNA polymerase of Hepatitis C virus | ChEMBL. | 15454222 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.